Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Go back to Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform| Gilead Sciences (NASDAQ: GILD) | Delayed: 143.97 -0.77 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.74 | 52 Week High | $108.63 | |||
| Open | $143.21 | 52 Week Low | $71.39 | |||
| Day High | $145.16 | P/E | 79.54 | |||
| Day Low | $142.79 | EPS | $1.81 | |||
| Volume | 1,754,781 | |||||



